It Begins: Gene-Editing The Next Human Generation

Europe gives green light to first gene therapy for children

In a global first, gene therapy that could prove life-saving for children has been recommended for approval in Europe.

The pioneering technology to fix faulty genes has been developed by Italian scientists and GlaxoSmithKline

FOX News reports:

The European Medicines Agency (EMA) said on Friday it had endorsed the therapy, called Strimvelis, for a tiny number of children with ADA Severe Combined Immune Deficiency (ADA-SCID) for whom no matching bone marrow donor is available.

Around 15 children a year are born in Europe with the ultra-rare genetic disorder, which leaves them unable to make a type of white blood cell. They rarely survive beyond two years unless their immune function is restored with a suitable bone marrow transplant.

Original Article:

Read More:DNA: How Technology Plays A Major Role In The Beast System

Read More:New Scientific Theory Suggests That Those With Blood Type RH Negative Could Belong To A Non-Human Lineage

Read More:Corrupting The Image Of God: GMO Scientists Now Developing Techniques To Intentionally Pollute Natural Organism’s Genomes To Permanently Alter Their DNA

1 Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.